In an era of rapid disruption and technological advancement, clinical operations leaders face mounting pressure to deliver greater effectiveness while navigating complex trade-offs. This webinar explores how organizations are rethinking...

Biologic therapies are transforming healthcare, but their complexity brings unique challenges for downstream quality control (QC). Ensuring product purity, safety, and consistency requires precise and reliable analytical methods, especially in...

Biopharmaceutical development requires a clear understanding of how process conditions affect product quality. For therapeutic antibodies, preserving biological activity—such as antigen binding and effector functions—depends on precise control of cell...

Join us on Wednesday, November 12th for a forward-looking event exploring the current and next generation of raw materials shaping the mRNA and oligo therapeutics landscapes. This event will bring...

We are very excited to invite you to the BVS and BioMed Realty Biotech Community Event in Cambridge! Mark your calendars for a great opportunity to connect with industry leaders,...

The Regional Biotechnology Conference is an annual conference that attracts more than 100 of the region’s movers and shakers for a half-day of dynamic speakers and topics that are important...

The minimum-viable-product concept was born not in advanced therapy, but in the tech sector. It asks: What's the smallest set of materials or features required to achieve the desired outcome?...

Following the first mRNA-LNP based Covid-19 vaccines, a plethora of new modalities were invented that are directed to treating and preventing diseases in previously unimaginable ways. With these new modalities,...